Genocea Biosciences (GNCA) Announces Proposed 10M Share Common Offering

Genocea Biosciences, Inc. (NASDAQ: GNCA) today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock. All the shares in the offering will be sold by Genocea. In addition, Genocea expects to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of its common stock sold in the public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.

SVB Leerink and Stifel are acting as joint book-running managers for the offering. Baird and Needham & Company are acting as co-managers for the offering.

You May Also Be Interested In

• Revolution (RVMD) PT Raised to $275 at Needham
• Stifel Reiterates Buy Rating on Arrowhead Pharma (ARWR)
• Space-Eyes signs option to acquire Navy engineering firm KMS Solutions